These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2445294)

  • 21. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
    Hasegawa S; Nakashima J; Nakashima Y; Nakamura S; Kimura S
    Hinyokika Kiyo; 1987 Dec; 33(12):2055-8. PubMed ID: 3329453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in biological markers for cancer.
    Klavins JV
    Ann Clin Lab Sci; 1983; 13(4):275-80. PubMed ID: 6194735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumor markers in testicular tumors].
    Jibiki K; Odagiri E; Demura R; Demura H; Yamaguchi Y
    Gan No Rinsho; 1985 Oct; 31(13):1709-16. PubMed ID: 3841165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
    Takakura N; Mimura H; Hamazaki K; Kim H; Hirata K; Miwata H; Kimura T; Sakata T; Hosoba T; Orita K
    Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor markers in testis cancer.
    Klein EA
    Urol Clin North Am; 1993 Feb; 20(1):67-73. PubMed ID: 7679533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological markers of human tumors and monitoring of cancer treatment.
    Tanneberger S; Nissen E; Ziegenbein R
    Arch Geschwulstforsch; 1979; 49(6):528-34. PubMed ID: 94534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent advancement of the treatment of urological malignancies].
    Akaza H
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():157-64. PubMed ID: 10410670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urogenital cancer].
    Koiso K; Rinsho K; Nemoto R; Ishikawa H; Ohtani M; Uchida K; Noguchi R
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):971-7. PubMed ID: 2658819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of microscopic findings and immunohistochemistry in the classification of necrotic testicular tumors: a study of 11 cases.
    Miller JS; Lee TK; Epstein JI; Ulbright TM
    Am J Surg Pathol; 2009 Sep; 33(9):1293-8. PubMed ID: 19461507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of six tumor markers (ferritin, CEA, TPA, AFP, PAP, gamma-Sm) in serum in patients with urogenital malignancies].
    Koizumi F; Nakamura E; Kawamura T; Ishimori A; Hoshi S; Matsuda S
    Rinsho Byori; 1986 Sep; 34(9):1053-8. PubMed ID: 2432295
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD; Patel MI; Sheinfeld J
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein.
    Hara M; Kimura H
    J Lab Clin Med; 1989 May; 113(5):541-8. PubMed ID: 2654306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y; Sakurai M; Hioki T; Hayashi N; Yamakawa K; Tajima K; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
    Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
    Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor markers in urological malignancies].
    Kuriyama M
    Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
    Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
    J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.